ch.oddb.org
 
Analysen | Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
 Sie befinden sich in - Home - Fachinformation zu Quetiapin Helvepharm
Fachinformation zu Quetiapin Helvepharm:Helvepharm AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info.
N05AH04 - QuetiapineATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N05 - Psycholeptics

The group is divided into therapeutic subgroups:
N05A - Antipsychotics
N05B - Anxiolytics
N05C - Hypnotics and sedatives

N05A - Antipsychotics

This group comprises drugs with antipsychotic actions (i.e. neuroleptics).
Reserpine is classified in C02 - Antihypertensives.
Antipsychotics in combination with antidepressants are classified in N06C - Psycholeptics and psychoanaleptics in combination.
The group is subdivided mainly according to chemical structure.

The DDDs are based on the treatment of psychosis. The substances in this group are sometimes used for other indications in much lower doses.
For depot injections, the DDDs are based on the average recommended doses divided by the dosing interval.

N05AH - Diazepines, Oxazepines, Thiazepines and Oxepines
 
N05AH04 - Quetiapine
StärkeAdm.RouteNote
0.4 gO 
LGPL2017 ywesee.com, Commit-ID
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home